Tango Therapeutics President, R&D Crystal Adam sells 27,000 shares
Tango Therapeutics Inc. President, R&D Crystal Adam exercised stock options for 27,000 shares at $5.20 on Oct. 1, 2026, and sold 27,000 shares at weighted average prices of $24.4547 and $25.32 the same day. Her direct holding fell to 115,743 shares.